NEW YORK (GenomeWeb News) – Beckman Coulter has inked a deal to be exclusive distributor outside of North America for IntelliCyt's HyperCyt system, an automated platform for multiplex cell- and bead-based screening.
Beckman also will hold co-exclusive distribution rights to the system in North America for use on its own CyAn flow cytometer. Beckman said that the combination will "create the fastest available flow cytometric cell analysis system."
Albuquerque, NM-based IntelliCyt will continue to provide direct sales and support of its HyperCyt system in North America.
"The combination of these two products will provide the capability for flow cytometry to reach an entirely new market segment where high throughput is essential," Brad Calvin,VP of Beckman Coulter's Flow Cytometry Business Center, said in a statement. "When the multidimensional cellular analysis capabilities of flow cytometry combine with high-throughput processing, more information can be generated from a single analysis than can be obtained with the drug discovery tools that are currently available."
Financial and further terms of the agreement were not disclosed.